<DOC>
	<DOCNO>NCT00730834</DOCNO>
	<brief_summary>Neuromonics TInnitus Treatment CALM study multi site study 100 adult subject clinically significant disturb tinnitus evaluate outcome measure use FDA clear Neuromonics treatment 6 , 12 , 24 36 month . Patients must meet certain inclusion criterion also required pay cost treatment . Subjects provide modest participation fee 6 , 12 , 24 36 month upon completion patient questionnaire ( subject must access computer internet order complete line questionnaire ) .</brief_summary>
	<brief_title>Customized Acoustic Stimulation Long Term Medical Benefit Relief Tinnitus Hyperacusis</brief_title>
	<detailed_description />
	<mesh_term>Tinnitus</mesh_term>
	<mesh_term>Hyperacusis</mesh_term>
	<criteria>18 year age , TRQ least 17 , Able pay treatment , Not use treatment tinnitus , Access computer internet , Compliant patient Hearing PTA &gt; 50 dB , score HADS great 11 anxiety depression scale , Not willing follow protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>tinnitus</keyword>
	<keyword>ring ear</keyword>
	<keyword>buzzing</keyword>
	<keyword>static</keyword>
	<keyword>hyperacusis</keyword>
	<keyword>loudness discomfort</keyword>
	<keyword>Clinically</keyword>
	<keyword>significant</keyword>
	<keyword>discomfort</keyword>
</DOC>